Wider statin use recommended for chronic kidney disease

December 10, 2013
Wider statin use recommended for chronic kidney disease

(HealthDay)—New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use, according to a clinical practice guideline published online Dec. 10 in the Annals of Internal Medicine.

Marcello Tonelli, M.D., from the University of Alberta in Edmonton, Canada, and colleagues reviewed and graded the evidence and developed a on lipid management and treatment of all adults and children with CKD.

The guidelines include 13 recommendations, with eight recommendations relating to assessment of lipid status and treatment with statin-based regimens. For adults ≥50 years with an estimated (eGFR) <60 mL/min/1.73 m², not treated with chronic dialysis or kidney transplantation, treatment with a statin or statin/ezetimibe combination is recommended. Statin treatment is recommended for adults aged ≥50 years with CKD and eGFR ≥60 mL/min/1.73 m². Younger adults (18 to 49 years) with CKD who are not treated with chronic dialysis or kidney transplantation should receive statin treatment if they have at least one of the following: known coronary disease, diabetes mellitus, prior ischemic stroke, or >10 percent estimated 10-year incidence of coronary death or non-fatal myocardial infarction. Statins or statin/ezetimibe combinations should not be initiated for adults with dialysis-dependent CKD, although treatment can be continued for those receiving it at dialysis initiation. Adult should also be treated with a statin. Adults with newly identified CKD should be evaluated with a lipid profile, but follow-up measurements are not required.

"Within the guideline, implications for clinical practice, future research, and implementation in international settings are highlighted," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further: ACP recommends against screening for chronic kidney disease in adults without symptoms, risk factors

More information: Full Text

Related Stories

ACC/AHA publish new guideline for management of blood cholesterol

November 12, 2013

The American College of Cardiology and the American Heart Association today released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, ...

Recommended for you

Ebola linked to habitat destruction

February 20, 2017

A Massey University veterinary scientist has co-authored research suggesting that Ebola virus emergence is linked to the clearing of animal habitat through deforestation in West and Central Africa.

New study determines how long Zika remains in body fluids

February 20, 2017

A study published in the New England Journal of Medicine provides evidence that the Zika virus particles remain longer in blood than in urine and some other body fluids. This information suggests that blood serum may be the ...

Researcher helps stem the spread of superbugs

February 20, 2017

Katherine Baker feels vindicated. She and other microbiologists have been warning for years that anti-bacterial soaps containing triclosan are bad for the environment, harmful for health, and do nothing to prevent disease.

Scientists uncover how Zika virus causes microcephaly

February 17, 2017

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered the mechanisms that the Zika virus uses to alter brain development. These findings are detailed in Stem Cell Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.